Diagnosis and Treatment > Signs and Symptoms

You are looking at 1 - 2 of 2 items for :

  • Weight gain x
  • Cutaneous pigmentation x
Clear All
Regina Streuli Division of Endocrinology and Diabetes, Department of Internal Medicine

Search for other papers by Regina Streuli in
Google Scholar
PubMed
Close
,
Ina Krull Division of Endocrinology and Diabetes, Department of Internal Medicine

Search for other papers by Ina Krull in
Google Scholar
PubMed
Close
,
Michael Brändle Division of Endocrinology and Diabetes, Department of Internal Medicine

Search for other papers by Michael Brändle in
Google Scholar
PubMed
Close
,
Walter Kolb Department of Surgery, Kantonsspital St Gallen, St Gallen, Switzerland

Search for other papers by Walter Kolb in
Google Scholar
PubMed
Close
,
Günter Stalla Clinical Neuroendocrinology, Max Planck Institute of Psychiatry, Munich, Germany

Search for other papers by Günter Stalla in
Google Scholar
PubMed
Close
,
Marily Theodoropoulou Clinical Neuroendocrinology, Max Planck Institute of Psychiatry, Munich, Germany

Search for other papers by Marily Theodoropoulou in
Google Scholar
PubMed
Close
,
Annette Enzler-Tschudy Institute of Pathology, Kantonsspital St Gallen, St Gallen, Switzerland

Search for other papers by Annette Enzler-Tschudy in
Google Scholar
PubMed
Close
, and
Stefan Bilz Division of Endocrinology and Diabetes, Department of Internal Medicine

Search for other papers by Stefan Bilz in
Google Scholar
PubMed
Close

Summary

Ectopic ACTH/CRH co-secreting tumors are a very rare cause of Cushing’s syndrome and only a few cases have been reported in the literature. Differentiating between Cushing’s disease and ectopic Cushing’s syndrome may be particularly difficult if predominant ectopic CRH secretion leads to pituitary corticotroph hyperplasia that may mimic Cushing’s disease during dynamic testing with both dexamethasone and CRH as well as bilateral inferior petrosal sinus sampling (BIPSS). We present the case of a 24-year-old man diagnosed with ACTH-dependent Cushing’s syndrome caused by an ACTH/CRH co-secreting midgut NET. Both high-dose dexamethasone testing and BIPSS suggested Cushing’s disease. However, the clinical presentation with a rather rapid onset of cushingoid features, hyperpigmentation and hypokalemia led to the consideration of ectopic ACTH/CRH-secretion and prompted a further workup. Computed tomography (CT) of the abdomen revealed a cecal mass which was identified as a predominantly CRH-secreting neuroendocrine tumor. To the best of our knowledge, this is the first reported case of an ACTH/CRH co-secreting tumor of the cecum presenting with biochemical features suggestive of Cushing’s disease.

Learning points:

  • The discrimination between a Cushing’s disease and ectopic Cushing’s syndrome is challenging and has many caveats.

  • Ectopic ACTH/CRH co-secreting tumors are very rare.

  • Dynamic tests as well as BIPSS may be compatible with Cushing’s disease in ectopic CRH-secretion.

  • High levels of CRH may induce hyperplasia of the corticotroph cells in the pituitary. This could be the cause of a preserved pituitary response to dexamethasone and CRH.

  • Clinical features of ACTH-dependent hypercortisolism with rapid development of Cushing’s syndrome, hyperpigmentation, high circulating levels of cortisol with associated hypokalemia, peripheral edema and proximal myopathy should be a warning flag of ectopic Cushing’s syndrome and lead to further investigations.

Open access
Ramez Ibrahim Royal Hallamshire Hospital, Sheffield, UK

Search for other papers by Ramez Ibrahim in
Google Scholar
PubMed
Close
,
Atul Kalhan University Hospital of Wales, Cardiff, UK

Search for other papers by Atul Kalhan in
Google Scholar
PubMed
Close
,
Alistair Lammie Cardiff University, Cardiff, UK

Search for other papers by Alistair Lammie in
Google Scholar
PubMed
Close
,
Christine Kotonya Bronglais Hospital, Aberystwyth, UK

Search for other papers by Christine Kotonya in
Google Scholar
PubMed
Close
,
Ravindra Nannapanenni University Hospital of Wales, Cardiff, UK

Search for other papers by Ravindra Nannapanenni in
Google Scholar
PubMed
Close
, and
Aled Rees Institute of Molecular and Experimental Medicine, Cardiff University, Cardiff, UK

Search for other papers by Aled Rees in
Google Scholar
PubMed
Close

Summary

A 30-year-old female presented with a history of secondary amenorrhoea, acromegalic features and progressive visual deterioration. She had elevated serum IGF1 levels and unsuppressed GH levels after an oral glucose tolerance test. Magnetic resonance imaging revealed a heterogeneously enhancing space-occupying lesion with atypical extensive calcification within the sellar and suprasellar areas. Owing to the extent of calcification, the tumour was a surgical challenge. Postoperatively, there was clinical, radiological and biochemical evidence of residual disease, which required treatment with a somatostatin analogue and radiotherapy. Mutational analysis of the aryl hydrocarbon receptor-interacting protein (AIP) gene was negative. This case confirms the relatively rare occurrence of calcification within a pituitary macroadenoma and its associated management problems. The presentation, biochemical, radiological and pathological findings are discussed in the context of the relevant literature.

Learning points

  • Calcification of pituitary tumours is relatively rare.

  • Recognising calcification in pituitary adenomas on preoperative imaging is important in surgical decision-making.

  • Gross total resection can be difficult to achieve in the presence of extensive calcification and dictates further management and follow-up to achieve disease control.

Open access